| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |